drugset / Trial / NCT04912115
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Multi-Center, Phase II, Randomized, Double-Blind, Prospective, Active Placebo-Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa-Induced Dyskinesia in Subjects with Parkinson's Disease.
Timeline
- Start
- 2021-10-05
- Primary completion
- 2023-12-30
- Completion
- 2024-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.1 mg/kg | Intravenous |
| Subject | Ketamine | Small molecule | 0.3 mg/kg | Intravenous |
| Comparator | Midazolam | Small molecule | 0.009 mg/kg | Intravenous |
| Comparator | Midazolam | Small molecule | 0.027 mg/kg | Intravenous |